N/A
Loading page data
Please wait a moment
Search Report
Loading page data
Please wait a moment
Iron deficiency anemia is considered to be one of a major global health problem affecting more than a million of the population other than any condition. Recombinant human transferrin consists of a polypeptide chain of amino acids. The recombinant human transferrin is a non-glycosylated produced in the plant.
The recombinant human transferrin purified by exclusive chromatographic methods. In cell culture applications, the recombinant human transferrin is an alternative method to blood-derived transferrin. Iron is essential for life and important for processes like DNA synthesis, electron transfer, and oxygen transport.
Deficiency or excess iron in the body can affect the above-mentioned processes and may impact the recombinant human transferrin market. Imbalance in the iron level can cause iron disorder such as hemochromatosis, aceruloplasminemia, atransferrinemia, Hemosiderosis.
According to the World Health Organization, Iron deficiency anemia affecting around more than 2 Bn population and is considered to be the most common cause of anemia globally. Especially, iron deficiency is less prevalent in developed countries, however, it remains a substantial health problem in the developed regions.
The multiple numbers of research and development and clinical studies have been done in the recombinant human transferrin area. Certainly, from over the past few years, extensive efforts have been focused towards exploring human serum transferrin, especially the use of recombinant native human transferrin and recombinant transferrin fusion proteins, for various applications.
Transferrin seems to be crucial for most cells growing in tissue culture. Recombinant human transferrin is a universal protein responsible for iron metabolism and transport and based on several studies it also helps in cell growth and productivity. This major function of recombinant human transferrin is expected to act as an instrumental driving factor to boost the growth of recombinant human transferrin market over the forecast years.
